New hope for tough cancers: first human trial of ITC-6146RO begins
Disease control
Not yet recruiting
This early-phase study tests a new drug, ITC-6146RO, in about 100 adults with advanced or metastatic cancers (lung, breast, prostate, or other solid tumors) that have stopped responding to standard therapies. The trial has two parts: first, finding the safest dose, then expanding…
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC